Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Cost effectiveness of alendronate for the treatment of male osteoporosis in Sweden.

Borgström F, Johnell O, Jönsson B, Zethraeus N, Sen SS.

Bone. 2004 Jun;34(6):1064-71.

PMID:
15193554
2.

The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature.

Fleurence RL, Iglesias CP, Johnson JM.

Pharmacoeconomics. 2007;25(11):913-33. Review.

PMID:
17960951
3.

Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women.

Kanis JA, Borgstrom F, Johnell O, Jonsson B.

Osteoporos Int. 2004 Nov;15(11):862-71. Epub 2004 Jun 3. Review.

PMID:
15175846
4.

Alendronate for the treatment of osteoporosis in men.

Olszynski WP, Davison KS.

Expert Opin Pharmacother. 2008 Feb;9(3):491-8. doi: 10.1517/14656566.9.3.491 . Review.

PMID:
18220499
5.

Cost-effectiveness of the treatment and prevention of osteoporosis--a review of the literature and a reference model.

Zethraeus N, Borgström F, Ström O, Kanis JA, Jönsson B.

Osteoporos Int. 2007 Jan;18(1):9-23. Epub 2006 Nov 9. Review.

PMID:
17093892
6.

Alendronate: an update of its use in osteoporosis.

Sharpe M, Noble S, Spencer CM.

Drugs. 2001;61(7):999-1039. Review.

PMID:
11434454
7.
8.

[Absolute risk for fracture and WHO guideline. Economic analysis of pharmacotherapy for osteoporosis].

Harada A; World Health Organization.

Clin Calcium. 2007 Jul;17(7):1029-34. Review. Japanese.

PMID:
17607069
9.

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.

10.

Background for studies on the treatment of male osteoporosis: state of the art.

Kaufman JM, Johnell O, Abadie E, Adami S, Audran M, Avouac B, Sedrine WB, Calvo G, Devogelaer JP, Fuchs V, Kreutz G, Nilsson P, Pols H, Ringe J, Van Haelst L, Reginster JY.

Ann Rheum Dis. 2000 Oct;59(10):765-72. Review.

11.

Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women.

Papapoulos SE, Quandt SA, Liberman UA, Hochberg MC, Thompson DE.

Osteoporos Int. 2005 May;16(5):468-74. Epub 2004 Sep 21. Review.

PMID:
15448985
12.

Osteoporosis in men.

Campion JM, Maricic MJ.

Am Fam Physician. 2003 Apr 1;67(7):1521-6. Review.

13.

Prevention of osteoporosis: cost-effectiveness of different pharmaceutical treatments.

Ankjaer-Jensen A, Johnell O.

Osteoporos Int. 1996;6(4):265-75. Review.

PMID:
8883114
14.
15.

[Difference in osteoporosis in men and women].

Iki M.

Clin Calcium. 2011 Sep;21(9):1377-83. doi: CliCa110913771383. Review. Japanese.

PMID:
21881201
16.

Alendronate in the treatment of osteoporosis: a review of the clinical trials.

Siris E.

J Womens Health Gend Based Med. 2000 Jul-Aug;9(6):599-606. Review.

PMID:
10957748
17.

[Treatment indications for osteoporosis].

Lamy O, Krieg MA, Burckhardt P.

Rev Med Suisse Romande. 2002 Aug;122(8):383-7. Review. French.

PMID:
12357731
18.

Osteoporosis in men.

Pande I, Francis RM.

Best Pract Res Clin Rheumatol. 2001 Jul;15(3):415-27. Review.

PMID:
11485338
19.

Is osteoporosis disease management cost effective?

Dell R, Greene D.

Curr Osteoporos Rep. 2010 Mar;8(1):49-55. doi: 10.1007/s11914-010-0009-0. Review.

PMID:
20425091
20.

Can alendronate help my osteoporosis?

Ashworth L.

Home Care Provid. 1997 Feb;2(1):37-42. Review.

PMID:
9188318

Supplemental Content

Support Center